{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:32:45Z","timestamp":1793406765870,"version":"4.5.0"},"reference-count":24,"publisher":"Informa UK Limited","issue":"9","license":[{"start":{"date-parts":[[2016,1,19]],"date-time":"2016-01-19T00:00:00Z","timestamp":1453161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA101140,CA102031,CA133250,CA140158"],"award-info":[{"award-number":["CA101140,CA102031,CA133250,CA140158"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Leukemia &amp; Lymphoma"],"published-print":{"date-parts":[[2016,9,1]]},"DOI":"10.3109\/10428194.2015.1135435","type":"journal-article","created":{"date-parts":[[2016,1,19]],"date-time":"2016-01-19T19:35:40Z","timestamp":1453232140000},"page":"2100-2108","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":36,"title":["Midostaurin, bortezomib and MEC in relapsed\/refractory acute myeloid leukemia"],"prefix":"10.3109","volume":"57","author":[{"given":"Alison R.","family":"Walker","sequence":"first","affiliation":[{"name":"Division of Hematology, Department of Medicine, The Ohio State University and the Comprehensive Cancer Center","place":["Columbus, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyan","family":"Wang","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, The Ohio State University and the Comprehensive Cancer Center","place":["Columbus, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Walsh","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, The Ohio State University and the Comprehensive Cancer Center","place":["Columbus, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavana","family":"Bhatnagar","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, The Ohio State University and the Comprehensive Cancer Center","place":["Columbus, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumithira","family":"Vasu","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, The Ohio State University and the Comprehensive Cancer Center","place":["Columbus, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramiro","family":"Garzon","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, The Ohio State University and the Comprehensive Cancer Center","place":["Columbus, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renee","family":"Canning","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, The Ohio State University and the Comprehensive Cancer Center","place":["Columbus, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Geyer","sequence":"additional","affiliation":[{"name":"Health Informatics Institute, University of South Florida","place":["Tampa, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue-Zhong","family":"Wu","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, The Ohio State University and the Comprehensive Cancer Center","place":["Columbus, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M.","family":"Devine","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, The Ohio State University and the Comprehensive Cancer Center","place":["Columbus, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Klisovic","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, The Ohio State University and the Comprehensive Cancer Center","place":["Columbus, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Blum","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, The Ohio State University and the Comprehensive Cancer Center","place":["Columbus, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Marcucci","sequence":"additional","affiliation":[{"name":"City of Hope Comprehensive Cancer Center, Gehr Family Center for Leukemia","place":["Duarte, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2016,1,19]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1406184"},{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.30.2554"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.50.6337"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-03-0772"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-08-109090"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403838"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2000.01831.x"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V95.11.3489"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-06-1845"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-06-1969"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00362-9"},{"key":"e_1_3_3_13_1","doi-asserted-by":"crossref","unstructured":"Stone RMS Sanford B et\u00a0al. The multi-kinase inhibitor midostaurin (M) prolongs survival compared with placebo (P) in combination with daunorubicin (D)\/cytarabine (C) induction (ind) high-dose c consolidation (consol) and as maintenance (maint) therapy in newly diganosed acute myeloid leukemia (AML) patients (pts) age 18\u201360 with FLT3 mutations (muts): an international prospective randomized (rand) P-controlled double-blind trial (CALGB 1063\/RATIFY [Alliance]). Blood. 2015;126:Abstract 6.","DOI":"10.1182\/blood.V126.23.6.6"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2010.03.008"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-08-110171"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-03-0508"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.45.2177"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.04.036"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-11-382226"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-03-413898"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2012.342"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.13285"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(11)70081-X"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.09.133"},{"key":"e_1_3_3_25_1","volume-title":"Blood","author":"Advani AS","year":"2014","unstructured":"Advani AS, Elson P, Kalaycio ME, et\u00a0al. Bortezomib\u2009+\u2009MEC (Mitoxantrone, Etoposide, Cytarabine) for relapsed\/refractory acute myeloid leukemia: final results of an expanded phase 1 trial. Blood. 2014;124:Abstract 978."}],"container-title":["Leukemia &amp; Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.3109\/10428194.2015.1135435","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.3109\/10428194.2015.1135435","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.3109\/10428194.2015.1135435","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:24:28Z","timestamp":1793406268000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.3109\/10428194.2015.1135435"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,19]]},"references-count":24,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9,1]]}},"alternative-id":["10.3109\/10428194.2015.1135435"],"URL":"https:\/\/doi.org\/10.3109\/10428194.2015.1135435","relation":{},"ISSN":["1042-8194","1029-2403"],"issn-type":[{"value":"1042-8194","type":"print"},{"value":"1029-2403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,19]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2015-10-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-12-04","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-12-14","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-01-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}